<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>KRISTALOSE- lactulose powder, for solution </strong><br>Cumberland Pharmaceuticals Inc.<br></p></div>
<h1>KRISTALOSE<span class="Sup">®</span><br>(LACTULOSE)
</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="dcl-dpl"></a><a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s1"></a><a name="section-1"></a><p></p>
<p class="First"><span class="Bold">For Oral Solution</span></p>
<table width="10%">
<col width="100.000%">
<tbody class="Headless"><tr class="First Last"><td class="Botrule Lrule Rrule Toprule" align="center"><p class="First"><span class="Bold">Rx only</span></p></td></tr></tbody>
</table>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="s2"></a><a name="section-2"></a><p></p>
<h1>DESCRIPTION
</h1>
<p class="First">KRISTALOSE<span class="Sup">®</span> (LACTULOSE) is a synthetic disaccharide in the form of crystals for reconstitution prior to use for oral administration. Each 10 g of lactulose contains less than 0.3 g galactose and lactose as a total sum. The pH range is 3.0 to 7.0.
</p>
<p>Lactulose is a colonic acidifier which promotes laxation.
</p>
<p>The chemical name for lactulose is 4-O-β-D-Galactopyranosyl-D-fructofuranose. It has the following structural formula:
</p>
<div class="Figure">
<a name="f01"></a><img alt="Structural Formula
" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=535dd1ea-b567-49f7-9a84-8ea91e78c466&amp;name=kri00-0000-01.jpg">
</div>
<p>The molecular formula is C<span class="Sub">12</span>H<span class="Sub">22</span>O<span class="Sub">11</span>. The molecular weight is 342.30. It is freely soluble in water.
</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="s3"></a><a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY
</h1>
<p class="First">KRISTALOSE<span class="Sup">®</span> (LACTULOSE) is poorly absorbed from the gastrointestinal tract and no enzyme capable of hydrolysis of this disaccharide is present in human gastrointestinal tissue. As a result, oral doses of lactulose reach the colon virtually unchanged. In the colon, lactulose is broken down primarily to lactic acid, and also to small amounts of formic and acetic acids, by the action of colonic bacteria, which results in an increase in osmotic pressure and slight acidification of the colonic contents. This in turn causes an increase in stool water content and softens the stool.
</p>
<p>Since lactulose does not exert its effect until it reaches the colon, and since transit time through the colon may be slow, 24 to 48 hours may be required to produce desired bowel movement.
</p>
<p>Lactulose given orally to man and experimental animals resulted in only small amounts reaching the blood. Urinary excretion has been determined to be 3% or less and is essentially complete within 24 hours.
</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="s4"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE
</h1>
<p class="First">KRISTALOSE<span class="Sup">®</span> (LACTULOSE) For Oral Solution is indicated for the treatment of <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>. In patients with a history of chronic <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>, lactulose therapy increases the number of bowel movements per day and the number of days on which bowel movements occur.
</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="s5"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS
</h1>
<p class="First">Since KRISTALOSE<span class="Sup">®</span> (LACTULOSE) For Oral Solution contains galactose (less than 0.3 g/10 g as a total sum with lactose), it is contraindicated in patients who require a low galactose diet.
</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="s6"></a><a name="section-6"></a><p></p>
<h1>WARNINGS
</h1>
<p class="First">A theoretical hazard may exist for patients being treated with lactulose who may be required to undergo electrocautery procedures during proctoscopy or colonoscopy. Accumulation of H<span class="Sub">2</span> gas in significant concentration in the presence of an electrical spark may result in an explosive reaction. Although this complication has not been reported with lactulose, patients on lactulose therapy undergoing such procedures should have a thorough bowel cleansing with a non-fermentable solution. Insufflation of CO<span class="Sub">2</span> as an additional safeguard may be pursued but is considered to be a redundant measure.
</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="s7"></a><a name="section-7"></a><p></p>
<h1>PRECAUTIONS
</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="s8"></a><a name="section-7.1"></a><p></p>
<h2>General
</h2>
<p class="First">Since KRISTALOSE<span class="Sup">®</span> (LACTULOSE) For Oral Solution contains galactose and lactose (less than 0.3 g/10 g as a total sum), it should be used with caution in diabetics.
</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="s9"></a><a name="section-7.2"></a><p></p>
<h2>Information for Patients
</h2>
<p class="First">In the event that an unusual diarrheal condition occurs, contact your physician.
</p>
</div>
<div class="Section" data-sectionCode="34075-2">
<a name="s10"></a><a name="section-7.3"></a><p></p>
<h2>Laboratory Tests
</h2>
<p class="First">Elderly, debilitated patients who receive lactulose for more than six months should have serum electrolytes (potassium, chloride, <span class="product-label-link" type="condition" conceptid="4135927" conceptname="Carbon dioxide">carbon dioxide</span>) measured periodically.
</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="s11"></a><a name="section-7.4"></a><p></p>
<h2>Drug Interactions
</h2>
<p class="First">Results of preliminary studies in humans and rats suggest that nonabsorbable antacids given concurrently with lactulose may inhibit the desired lactulose-induced drop in colonic pH. Therefore, a possible lack of desired effect of treatment should be taken into consideration before such drugs are given concomitantly with lactulose.
</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="s12"></a><a name="section-7.5"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility
</h2>
<p class="First">There are no known human data on long-term potential for carcinogenicity, mutagenicity, or impairment of fertility.
</p>
<p>There are no known animal data on long-term potential for mutagenicity.
</p>
<p>Administration of lactulose syrup in the diet of mice for 18 months in concentrations of 3 and 10 percent (v/w) did not produce any evidence of carcinogenicity.
</p>
<p>In studies in mice, rats, and rabbits, doses of lactulose syrup up to 6 or 12 mL/kg/day produced no deleterious effects in breeding, conception, or parturition.
</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="s13"></a><a name="section-7.6"></a><p></p>
<h2>Pregnancy
</h2>
<div class="Section" data-sectionCode="34077-8">
<a name="s14"></a><a name="section-7.6.1"></a><p></p>
<h3>Teratogenic Effects
</h3>
<div class="Section" data-sectionCode="42229-5">
<a name="e13"></a><a name="section-7.6.1.1"></a><p></p>
<h4>Pregnancy Category B
</h4>
<p class="First">Reproduction studies have been performed in mice, rats, and rabbits at doses up to 3 or 6 times the usual human oral dose and have revealed no evidence of impaired fertility or harm to the fetus due to lactulose. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.
</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="s15"></a><a name="section-7.7"></a><p></p>
<h2>Nursing Mothers
</h2>
<p class="First">It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when lactulose is administered to a nursing woman.
</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="s16"></a><a name="section-7.8"></a><p></p>
<h2>Pediatric Use
</h2>
<p class="First">Safety and effectiveness in pediatric patients have not been established.
</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="s17"></a><a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS
</h1>
<p class="First">Precise frequency data are not available.
</p>
<p>Initial dosing may produce <span class="product-label-link" type="condition" conceptid="4012503" conceptname="Excessive upper gastrointestinal gas">flatulence</span> and <span class="product-label-link" type="condition" conceptid="4091963" conceptname="Bowel spasm">intestinal cramps</span>, which are usually transient. Excessive dosage can lead to <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> with potential complications such as loss of fluids, <span class="product-label-link" type="condition" conceptid="437833" conceptname="Hypokalemia">hypokalemia</span>, and <span class="product-label-link" type="condition" conceptid="4190305" conceptname="Hypernatremia">hypernatremia</span>.
</p>
<p><span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">Nausea</span> and <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span> have been reported.
</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="s18"></a><a name="section-9"></a><p></p>
<h1>OVERDOSAGE
</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="s19"></a><a name="section-9.1"></a><p></p>
<h2>Signs and Symptoms
</h2>
<p class="First">There have been no reports of accidental overdosage. In the event of overdosage, it is expected that <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> and <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal cramps</span> would be the major symptoms. Medication should be terminated.
</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s20"></a><a name="section-9.2"></a><p></p>
<h2>Oral LD<span class="Sub">50</span>
</h2>
<p class="First">The acute oral LD<span class="Sub">50</span> of the drug is 48.8 mL/kg in mice and greater than 30 mL/kg in rats.
</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s21"></a><a name="section-9.3"></a><p></p>
<h2>Dialysis
</h2>
<p class="First">Dialysis data are not available for lactulose. Its molecular similarity to sucrose, however, would suggest that it should be dialyzable.
</p>
</div>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="s22"></a><a name="section-10"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION
</h1>
<p class="First">The usual adult dosage is 10 g to 20 g of lactulose daily. The dose may be increased to 40 g daily if necessary. Twenty-four to 48 hours may be required to produce a normal bowel movement.
</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="s23"></a><a name="section-11"></a><p></p>
<h1>DIRECTIONS FOR PREPARATION
</h1>
<p class="First">Dissolve contents of packet in half a glass (4 ounces) of water.
</p>
<p>When Lactulose For Oral Solution is dissolved in water, the resulting solution may be colorless to a slightly <span class="product-label-link" type="condition" conceptid="4260836" conceptname="Blanching of skin">pale</span> yellow color.
</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="s24"></a><a name="section-12"></a><p></p>
<h1>HOW SUPPLIED
</h1>
<p class="First">KRISTALOSE<span class="Sup">®</span> (LACTULOSE) For Oral Solution is available in single dose packets of 10 g (NDC 66220-719-01) and single dose packets of 20 g (NDC 66220-729-01). The packets are supplied as follows:
</p>
<dl>
<dt> 
</dt>
<dd>NDC 66220-719-30
</dd>
<dt> 
</dt>
<dd>(Carton of thirty 10 g packets)
</dd>
<dt> 
</dt>
<dd>NDC 66220-729-30
</dd>
<dt> 
</dt>
<dd>(Carton of thirty 20 g packets)
</dd>
</dl>
<p><span class="Bold">STORE AT ROOM TEMPERATURE, 15°-30°C (59°-86°F).</span></p>
<p>To report adverse events associated with this product, please call 1-877-484-2700.
</p>
<p>www.kristalose.com
</p>
<p>Manufactured for:<br>CUMBERLAND<br>PHARMACEUTICALS INC.<br>Nashville, TN 37203<br>KPI 021201
</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="s25"></a><a name="section-13"></a><p></p>
<p class="First">Principal Display panel – 10 Grams Carton Label
</p>
<p>NDC 66220-719-30
</p>
<p><span class="Bold">Kristalose</span><span class="Sup">® </span><span class="Bold">( lactulose )<br>For Oral Solution</span></p>
<p><span class="Bold">10 Grams<br></span>30 Single Dose Packets
</p>
<p>CUMBERLAND<span class="Sup">®</span></p>
<p>PHARMACEUTICALS
</p>
<p><span class="Bold">Rx only</span></p>
<div class="Figure">
<a name="f02"></a><img alt="Principal Display panel – 10 Grams Carton Label
" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=535dd1ea-b567-49f7-9a84-8ea91e78c466&amp;name=kri00-0000-02.jpg">
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="s26"></a><a name="section-14"></a><p></p>
<p class="First">Principal Display Panel – 10 Grams Pouch Label
</p>
<p>NDC 66220-719-01<br><span class="Bold">Kristalose</span><span class="Sup">® </span><span class="Bold">( lactulose )<br>For Oral Solution</span></p>
<p>CUMBERLAND<span class="Sup">®</span></p>
<p>PHARMACEUTICALS
</p>
<p><span class="Bold">10 Grams<br></span>Single Dose Packet
</p>
<p><span class="Bold">Rx only</span></p>
<p><span class="Bold">CONTENTS:</span> Each packet contains 10 grams lactulose (and less than 0.3 g galactose and lactose as a total sum).
</p>
<p>This unit dose packet is not child resistant.
</p>
<p><span class="Bold">INDICATIONS:</span> For the treatment of <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>. See accompanying package insert.
</p>
<p><span class="Bold">USUAL ADULT DOSAGE:</span> 10 to 20 grams daily. See accompanying package insert.
</p>
<p>Since lactulose does not exert its effect until it reaches the colon, and since transit time through the colon may be slow, 24-48 hours may be required to produce a normal bowl movement.
</p>
<p><span class="Bold">DIRECTIONS FOR PREPARATION:</span> Dissolve contents of packet in half a glass (4 ounces) of water.
</p>
<p>Store at room temperature, 15°-30°C (59°-86°F).
</p>
<p><span class="Bold">Manufactured for:<br>Cumberland Pharmaceuticals Inc.<br>Nashville, TN, USA, 37203</span></p>
<div class="Figure">
<a name="f03"></a><img alt="Principal Display Panel – 10 Grams Pouch Label
" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=535dd1ea-b567-49f7-9a84-8ea91e78c466&amp;name=kri00-0000-03.jpg">
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="s27"></a><a name="section-15"></a><p></p>
<p class="First">Principal Display panel – 20 Grams Carton Label
</p>
<p>NDC 66220-729-30
</p>
<p><span class="Bold">Kristalose</span><span class="Sup">® </span><span class="Bold">( lactulose )<br>For Oral Solution</span></p>
<p><span class="Bold">20 Grams<br></span>30 Single Dose Packets
</p>
<p>CUMBERLAND<span class="Sup">®</span></p>
<p>PHARMACEUTICALS
</p>
<p><span class="Bold">Rx only</span></p>
<div class="Figure">
<a name="f04"></a><img alt="Principal Display panel – 20 Grams Carton Label
" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=535dd1ea-b567-49f7-9a84-8ea91e78c466&amp;name=kri00-0000-04.jpg">
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="s28"></a><a name="section-16"></a><p></p>
<p class="First">Principal Display Panel – 20 Grams Pouch Label
</p>
<p>NDC 66220-729-01<br><span class="Bold">Kristalose</span><span class="Sup">® </span><span class="Bold">( lactulose )<br>For Oral Solution</span></p>
<p>CUMBERLAND<span class="Sup">®</span></p>
<p>PHARMACEUTICALS
</p>
<p><span class="Bold">20 Grams<br></span>Single Dose Packet
</p>
<p><span class="Bold">Rx only</span></p>
<p><span class="Bold">CONTENTS:</span> Each packet contains 20 grams lactulose (and less than 0.6 g galactose and lactose as a total sum).
</p>
<p>This unit dose packet is not child resistant.
</p>
<p><span class="Bold">INDICATIONS:</span> For the treatment of <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>. See accompanying package insert.
</p>
<p><span class="Bold">USUAL ADULT DOSAGE:</span> 10 to 20 grams daily. See accompanying package insert.
</p>
<p>Since lactulose does not exert its effect until it reaches the colon, and since transit time through the colon may be slow, 24-48 hours may be required to produce a normal bowl movement.
</p>
<p><span class="Bold">DIRECTIONS FOR PREPARATION:</span> Dissolve contents of packet in half a glass (4 ounces) of water.
</p>
<p>Store at room temperature, 15°-30°C (59°-86°F).
</p>
<p><span class="Bold">Manufactured for:<br>Cumberland Pharmaceuticals Inc.<br>Nashville, TN, USA, 37203</span></p>
<div class="Figure">
<a name="f05"></a><img alt="Principal Display Panel – 20 Grams Pouch Label
" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=535dd1ea-b567-49f7-9a84-8ea91e78c466&amp;name=kri00-0000-05.jpg">
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>KRISTALOSE 		
					</strong><br><span class="contentTableReg">lactulose powder, for solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:66220-719</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>lactulose</strong> (lactulose) </td>
<td class="formItem">lactulose</td>
<td class="formItem">10 g  in 10 g</td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:66220-719-30</td>
<td class="formItem">30  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:66220-719-01</td>
<td class="formItem">10 g in 1 POUCH</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA074712</td>
<td class="formItem">01/20/2012</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>KRISTALOSE 		
					</strong><br><span class="contentTableReg">lactulose powder, for solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:66220-729</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>lactulose</strong> (lactulose) </td>
<td class="formItem">lactulose</td>
<td class="formItem">20 g  in 20 g</td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:66220-729-30</td>
<td class="formItem">30  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:66220-729-01</td>
<td class="formItem">20 g in 1 POUCH</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA074712</td>
<td class="formItem">01/20/2012</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Cumberland Pharmaceuticals Inc.
							(069532880)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 9/2012<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>345383dc-2e49-462c-b304-d49c3be6783e</div>
<div>Set id: 535dd1ea-b567-49f7-9a84-8ea91e78c466</div>
<div>Version: 1</div>
<div>Effective Time: 20120921</div>
</div>
</div> <div class="DistributorName">Cumberland Pharmaceuticals Inc.</div></p>
</body></html>
